Jardiance

Medically Reviewed by Dr. Harshi Dhingra, M.D.

Last Reviewed: Jul 18, 2022

Drug Details

Generic Name:

Empagliflozin

Common Brands:

Jardiance

Availability:

Prescription only

Therapeutic Class:

SGLT2 inhibitors

Forms:

Tablet

Administration:

By mouth

Therapeutic Uses:

To improve glycemic control and lower blood glucose levels in adults with type 2 diabetes mellitus
To lower the risk of cardiovascular death from stroke and heart attack in people with heart disease and diabetes

Controlled Status:

Not a controlled substance

Jardiance (empagliflozin) Drug Class

Jardiance (empagliflozin [em pa glih floe zin]) belongs to a group of medications called SGLT2 inhibitors which are oral diabetes medications. It is a prescription oral diabetes medication used to improve glycemic control (lower blood sugar levels) in adults with type 2 diabetes mellitus. Jardiance (empagliflozin) is also used to lower the risk of death from cardiovascular events like stroke and heart attack in people with established cardiovascular disease and diabetes.